Back to all cases
Dapagliflozin
🇺🇸 United States·2022
Collected
Throughput AccountingPharmaceuticals
Case Summary
Dapagliflozin attenuates severity of atherosclerosis through manufacturing energy-crisis to inhibit ferroptosis of macrophage.
Source
- Title
- Dapagliflozin Attenuates Severity of Atherosclerosis through Manufacturing Energy-Crisis to Inhibit Ferroptosis of Macrophage
- Type
- academic paper
- Year
- 2022
- Confidence Score
- 90%